相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。miR-137 mediates the functional link between c-Myc and EZH2 that regulates cisplatin resistance in ovarian cancer
Jing Sun et al.
ONCOGENE (2019)
A Whole-genome CRISPR Screen Identifies a Role of MSH2 in Cisplatin-mediated Cell Death in Muscle-invasive Bladder Cancer
Andrew Goodspeed et al.
EUROPEAN UROLOGY (2019)
MRP4/ABCC4 As a New Therapeutic Target: Meta-Analysis to Determine cAMP Binding Sites as a Tool for Drug Design
Agustin Yaneff et al.
CURRENT MEDICINAL CHEMISTRY (2019)
Regulation of OCT2 transcriptional repression by histone acetylation in renal cell carcinoma
Qianying Zhu et al.
EPIGENETICS (2019)
Cisplatin resistance involves a metabolic reprogramming through ROS and PGC-1α in NSCLC which can be overcome by OXPHOS inhibition
Alberto Cruz-Bermudez et al.
FREE RADICAL BIOLOGY AND MEDICINE (2019)
Inositol-triphosphate 3-kinase B confers cisplatin resistance by regulating NOX4-dependent redox balance
Chaoyun Pan et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Loss of Scribble confers cisplatin resistance during NSCLC chemotherapy via Nox2/ROS and Nrf2/PD-L1 signaling
Na Wang et al.
EBIOMEDICINE (2019)
Knockdown of galectin-1 facilitated cisplatin sensitivity by inhibiting autophagy in neuroblastoma cells
Jie Gao et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2019)
Omeprazole protects against cisplatin-induced nephrotoxicity by alleviating oxidative stress, inflammation, and transporter-mediated cisplatin accumulation in rats and HK-2 cells
Huan Gao et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2019)
HIF-1-Dependent Reprogramming of Glucose Metabolic Pathway of Cancer Cells and Its Therapeutic Significance
Ayako Nagao et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
LncRNA MALAT1 potentiatesautophagy-associated cisplatin resistance by regulating the microRNA-30b/autophagy-related gene 5 axis in gastric cancer
Zhiwen Xi et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2019)
Profiling of apoptosis- and autophagy-associated molecules in human lung cancer A549 cells in response to cisplatin treatment using stable isotope labeling with amino acids in cell culture
Zongqiang Wang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2019)
LncRNA BLACAT1 is involved in chemoresistance of non-small cell lung cancer cells by regulating autophagy
Feng-Xiang Huang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2019)
miR-34a regulates the chemosensitivity of retinoblastoma cells via modulation of MAGE-A/p53 signaling
Ge Yang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2019)
Tetrathiomolybdate induces dimerization of the metal-binding domain of ATPase and inhibits platination of the protein
Tiantian Fang et al.
NATURE COMMUNICATIONS (2019)
Emerging platinum(IV) prodrugs to combat cisplatin resistance: from isolated cancer cells to tumor microenvironment
Zhigang Wang et al.
DALTON TRANSACTIONS (2019)
Exosomal miR-196a derived from cancer-associated fibroblasts confers cisplatin resistance in head and neck cancer through targeting CDKN1B and ING5
Xing Qin et al.
GENOME BIOLOGY (2019)
Glutathione reductase mediates drug resistance in glioblastoma cells by regulating redox homeostasis
Zhongling Zhu et al.
JOURNAL OF NEUROCHEMISTRY (2018)
MiR-5100 increases the cisplatin resistance of the lung cancer stem cells by inhibiting the Rab6
Lawei Yang et al.
MOLECULAR CARCINOGENESIS (2018)
Reversal of cisplatin resistance by microRNA-139-5p-independent RNF2 downregulation and MAPK inhibition in ovarian cancer
Ying Chen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2018)
Gambogic Acid Inhibits Melanoma through Regulation of miR-199a-3p/ZEB1 Signalling
Lili Liang et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2018)
MircroRNA-139 sensitizes ovarian cancer cell to cisplatin-based chemotherapy through regulation of ATP7A/B
Fang Xiao et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2018)
DUOXA1-mediated ROS production promotes cisplatin resistance by activating ATR-Chk1 pathway in ovarian cancer
Yunxiao Meng et al.
CANCER LETTERS (2018)
Phase II study of adjuvant chemotherapy with paclitaxel and nedaplatin for uterine cervical cancer with lymph node metastasis
Munetaka Takekuma et al.
CANCER SCIENCE (2018)
Targeting the microenvironment in solid tumors
Carmen Belli et al.
CANCER TREATMENT REVIEWS (2018)
BRCA Mutation and Its Association With Colorectal Cancer
Aixa E. Soyano et al.
CLINICAL COLORECTAL CANCER (2018)
Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/β-catenin signaling pathways by up-regulating miR-34a
Chuanyao Cheng et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2018)
ABT737 reverses cisplatin resistance by targeting glucose metabolism of human ovarian cancer cells
Yunjie Xu et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2018)
MicroRNA-125a-5p enhances the sensitivity of esophageal squamous cell carcinoma cells to cisplatin by suppressing the activation of the STAT3 signaling pathway
Yan Zhao et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2018)
Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway
Tianxiao Gong et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2018)
Relevance of copper transporter 1 and organic cation transporters 1-3 for oxaliplatin uptake and drug resistance in colorectal cancer cells
I. Buss et al.
METALLOMICS (2018)
Autocrine activation of JAK2 by IL-11 promotes platinum drug resistance
Wei Zhou et al.
ONCOGENE (2018)
miR-181 regulates cisplatin-resistant non-small cell lung cancer via downregulation of autophagy through the PTEN/PI3K/AKT pathway
Jiangang Liu et al.
ONCOLOGY REPORTS (2018)
A HIF-independent, CD133-mediated mechanism of cisplatin resistance in glioblastoma cells
Eroje M. Ahmed et al.
CELLULAR ONCOLOGY (2018)
Downregulation of HIF-2α Reverse the Chemotherapy Resistance of Lung Adenocarcinoma A549 Cells to Cisplatin
Zhao-jia Gao et al.
MEDICAL SCIENCE MONITOR (2018)
Cisplatin and Pemetrexed Activate AXL and AXL Inhibitor BGB324 Enhances Mesothelioma Cell Death from Chemotherapy
Derek B. Oien et al.
FRONTIERS IN PHARMACOLOGY (2018)
LncRNA HOXA11-AS drives cisplatin resistance of human LUAD cells via modulating miR-454-3p/Stat3
Xia Zhao et al.
CANCER SCIENCE (2018)
Comparison of efficacy and toxicity between nedaplatin and cisplatin in treating malignant pleural effusion
Li-Zhe Zhong et al.
ONCOTARGETS AND THERAPY (2018)
Induction of p53 Phosphorylation at Serine 20 by Resveratrol Is Required to Activate p53 Target Genes, Restoring Apoptosis in MCF-7 Cells Resistant to Cisplatin
Jorge Hernandez-Valencia et al.
NUTRIENTS (2018)
Activated Integrated Stress Response Induced by Salubrinal Promotes Cisplatin Resistance in Human Gastric Cancer Cells via Enhanced xCT Expression and Glutathione Biosynthesis
Sheng-Fan Wang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
miR-874 regulates multiple-drug resistance in gastric cancer by targeting ATG16L1
Haijin Huang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2018)
Therapy resistance mediated by cancer stem cells
Teresa Bernadette Steinbichler et al.
SEMINARS IN CANCER BIOLOGY (2018)
Autophagy regulates cisplatin-induced stemness and chemoresistance via the upregulation of CD44, ABCB1 and ADAM17 in oral squamous cell carcinoma
Prajna Paramita Naik et al.
CELL PROLIFERATION (2018)
GFRA1 promotes cisplatin-induced chemoresistance in osteosarcoma by inducing autophagy
Mihwa Kim et al.
AUTOPHAGY (2017)
A phase 2 study of nanoparticle albumin-bound paclitaxel plus nedaplatin for patients with advanced, recurrent, or metastatic cervical carcinoma
Yifan Li et al.
CANCER (2017)
Functional Activation of Mutant p53 by Platinum Analogues in Cisplatin-Resistant Cells Is Dependent on Phosphorylation
Xiaolei Xie et al.
MOLECULAR CANCER RESEARCH (2017)
The FA/BRCA Pathway Identified as the Major Predictor of Cisplatin Response in Head and Neck Cancer by Functional Genomics
Sanne R. Martens-de kemp et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Wwox-Brca1 interaction: role in DNA repair pathway choice
M. S. Schrock et al.
ONCOGENE (2017)
miR-374a-CCND 1-pPI3KJAKT-c-JUN feedback loop modulated by PDCD4 suppresses cell growth, metastasis, and sensitizes nasopharyngeal carcinoma to cisplatin
Y. Zhen et al.
ONCOGENE (2017)
Multi-institutional prospective study of nedaplatin plus S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-containing regimens
Pei-Jian Peng et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2017)
miR-148a increases the sensitivity to cisplatin by targeting Rabl4 in renal cancer cells
Eun-Ae Kim et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
PGRMC1-dependent autophagy by hyperoside induces apoptosis and sensitizes ovarian cancer cells to cisplatin treatment
Xiaofei Zhu et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
Resveratrol-induced autophagy and apoptosis in cisplatin-resistant human oral cancer CAR cells: A key role of AMPK and Akt/mTOR signaling
Chao-Hsiang Chang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
Interactions of cisplatin and the copper transporter CTR1 in human colon cancer cells
Mia C. Akerfeldt et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2017)
Exosomal transfer of tumor-associated macrophage-derived miR-21 confers cisplatin resistance in gastric cancer cells
Peiming Zheng et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Competitive reactions among glutathione, cisplatin and copper-phenanthroline complexes
Enzo Cadoni et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2017)
Histone Methyltransferase G9a Drives Chemotherapy Resistance by Regulating the Glutamate-Cysteine Ligase Catalytic Subunit in Head and Neck Squamous Cell Carcinoma
Chia-Wen Liu et al.
MOLECULAR CANCER THERAPEUTICS (2017)
ABCF2, an Nrf2 target gene, contributes to cisplatin resistance in ovarian cancer cells
Lingjie Bao et al.
MOLECULAR CARCINOGENESIS (2017)
Mxd1 mediates hypoxia-induced cisplatin resistance in osteosarcoma cells by repression of the PTEN tumor suppressor gene
Datong Zheng et al.
MOLECULAR CARCINOGENESIS (2017)
A subset of platinum-containing chemotherapeutic agents kills cells by inducing ribosome biogenesis stress
Peter M. Bruno et al.
NATURE MEDICINE (2017)
RAD6 promotes DNA repair and stem cell signaling in ovarian cancer and is a promising therapeutic target to prevent and treat acquired chemoresistance
R. R. Somasagara et al.
ONCOGENE (2017)
Lysine-specific demethylase KDM3A regulates ovarian cancer stemness and chemoresistance
S. Ramadoss et al.
ONCOGENE (2017)
Classification Systems of Secondary Active Transporters
Emelie Perland et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2017)
miR-34a mediates oxaliplatin resistance of colorectal cancer cells by inhibiting macroautophagy via transforming growth factor-β/Smad4 pathway
Chen Sun et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Cytoplasmic fragment of CD147 generated by regulated intramembrane proteolysis contributes to HCC by promoting autophagy
Bo Wu et al.
CELL DEATH & DISEASE (2017)
USP13 regulates the RAP80-BRCA1 complex dependent DNA damage response
Yunhui Li et al.
NATURE COMMUNICATIONS (2017)
Let-7e sensitizes epithelial ovarian cancer to cisplatin through repressing DNA double strand break repair
Man Xiao et al.
JOURNAL OF OVARIAN RESEARCH (2017)
LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression
Zheng Fang et al.
CANCER MEDICINE (2017)
ZBTB7A Enhances Osteosarcoma Chemoresistance by Transcriptionally Repressing lncRNALINC00473-IL24 Activity
Lu Zhang et al.
NEOPLASIA (2017)
MiR-200c regulates tumor growth and chemosensitivity to cisplatin in osteosarcoma by targeting AKT2
Yang Liu et al.
SCIENTIFIC REPORTS (2017)
LncRNA XIST promotes human lung adenocarcinoma cells to cisplatin resistance via let-7i/BAG-1 axis
Jing Sun et al.
CELL CYCLE (2017)
MicroRNA-148a-3p enhances cisplatin cytotoxicity in gastric cancer through mitochondrial fission induction and cyto-protective autophagy suppression
Bowen Li et al.
CANCER LETTERS (2017)
MicroRNA-195 acts as an anti-proliferative miRNA in human melanoma cells by targeting Prohibitin 1
Priscila Daniele Ramos Cirilo et al.
BMC CANCER (2017)
Recent advance in the pharmacogenomics of human Solute Carrier Transporters (SLCs) in drug disposition
Fanfan Zhou et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Long non-coding RNA AC023115.3 suppresses chemoresistance of glioblastoma by reducing autophagy
Binbin Ma et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2017)
XPF knockout via CRISPR/Cas9 reveals that ERCC1 is retained in the cytoplasm without its heterodimer partner XPF
Janin Lehmann et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2017)
MiR-216b increases cisplatin sensitivity in ovarian cancer cells by targeting PARP1
Y. Liu et al.
CANCER GENE THERAPY (2017)
Pseudohypoxia induced by miR-126 deactivation promotes migration and therapeutic resistance in renal cell carcinoma
Weijun Liu et al.
CANCER LETTERS (2017)
HIF-1 in cancer therapy: two decade long story of a transcription factor
Sourabh Soni et al.
ACTA ONCOLOGICA (2017)
Up-regulation of miR-146a increases the sensitivity of non-small cell lung cancer to DDP by downregulating cyclin J
Lin Shi et al.
BMC CANCER (2017)
The role of Nrf2 and ATF2 in resistance to platinum-based chemotherapy
Jianli Chen et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
NF-κB signaling plays irreplaceable roles in cisplatin-induced bladder cancer chemoresistance and tumor progression
Yi Sun et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
CRISPR-Cas9-based target validation for p53-reactivating model compounds
Ichael Wanzel et al.
NATURE CHEMICAL BIOLOGY (2016)
Hypoxia-inducible factor 3 biology: complexities and emerging themes
Cunming Duan
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2016)
KLF5 mediates vascular remodeling via HIF-1α in hypoxic pulmonary hypertension
Xiaochen Li et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2016)
Role for DUSP1 (dual-specificity protein phosphatase 1) in the regulation of autophagy
Juan Wang et al.
AUTOPHAGY (2016)
Lobaplatin induces BGC-823 human gastric carcinoma cell apoptosis via ROS-mitochondrial apoptotic pathway and impairs cell migration and invasion
Yali Li et al.
BIOMEDICINE & PHARMACOTHERAPY (2016)
Long non-coding RNA UCA1 promotes cisplatin/gemcitabine resistance through CREB modulating miR-196a-5p in bladder cancer cells
Jingjing Pan et al.
CANCER LETTERS (2016)
Overcoming cisplatin resistance of ovarian cancer cells by targeting HIF-1-regulated cancer metabolism
Zhihong Ai et al.
CANCER LETTERS (2016)
Lung cancer stem cells: The root of resistance
Lauren MacDonagh et al.
CANCER LETTERS (2016)
Effector T Cells Abrogate Stroma-Mediated Chemoresistance in Ovarian Cancer
Weimin Wang et al.
CELL (2016)
The African-specific S47 polymorphism of p53 alters chemosensitivity
Subhasree Basu et al.
CELL CYCLE (2016)
Microenvironmental InterFereNce of metabolism regulates chemosensitivity
Leila Akkari et al.
CELL RESEARCH (2016)
An African-specific polymorphism in the TP53 gene impairs p53 tumor suppressor function in a mouse model
Matthew Jennis et al.
GENES & DEVELOPMENT (2016)
MiR-99a and MiR-491 Regulate Cisplatin Resistance in Human Gastric Cancer Cells by Targeting CAPNS1
Yajie Zhang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2016)
Higher expression of XPF is a critical factor in intrinsic chemotherapy resistance of human renal cell carcinoma
Qiao Zhang et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
miR-133a enhances the sensitivity of Hep-2 cells and vincristine-resistant Hep-2v cells to cisplatin by downregulating ATP7B expression
Xurui Wang et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2016)
miR-409-3p sensitizes colon cancer cells to oxaliplatin by inhibiting Beclin-1-mediated autophagy
Shifan Tan et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2016)
miR-17-92 plays an oncogenic role and conveys chemo-resistance to cisplatin in human prostate cancer cells
Peng Zhou et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Cisplatin-induced CCL5 secretion from CAFs promotes cisplatin-resistance in ovarian cancer via regulation of the STAT3 and PI3K/Akt signaling pathways
Bo Zhou et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Cathepsin Protease Controls Copper and Cisplatin Accumulation via Cleavage of the Ctr1 Metal-binding Ectodomain
Helena Ohrvik et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Copper transporters and chaperones CTR1, CTR2, ATOX1, and CCS as determinants of cisplatin sensitivity
Kristin M. Bompiani et al.
METALLOMICS (2016)
OCT2 demethylation cracks open oxaliplatin resistance
Andrea Aguilar
Nature Reviews Nephrology (2016)
Oxaliplatin-Based Chemotherapy in Advanced Neuroendocrine Tumors: Clinical Outcomes and Preliminary Correlation with Biological Factors
Francesca Spada et al.
NEUROENDOCRINOLOGY (2016)
Downregulation of YEATS4 by miR-218 sensitizes colorectal cancer cells to L-OHP-induced cell apoptosis by inhibiting cytoprotective autophagy
Qiang Fu et al.
ONCOLOGY REPORTS (2016)
Enhancement of Drug Sensitivity by Knockdown of HIF-1α in Gastric Carcinoma Cells
Qun Zhao et al.
ONCOLOGY RESEARCH (2016)
Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer
Caroline Wigerup et al.
PHARMACOLOGY & THERAPEUTICS (2016)
Epigenetic activation of the drug transporter OCT2 sensitizes renal cell carcinoma to oxaliplatin
Yanqing Liu et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
A phosphotyrosine switch regulates organic cation transporters
Jason A. Sprowl et al.
NATURE COMMUNICATIONS (2016)
Ammonium tetrathiomolybdate treatment targets the copper transporter ATP7A and enhances sensitivity of breast cancer to cisplatin
Cristine L. Chisholm et al.
ONCOTARGET (2016)
Cancer-associated fibroblasts treated with cisplatin facilitates chemoresistance of lung adenocarcinoma through IL-11/IL-11R/STAT3 signaling pathway
Leilei Tao et al.
SCIENTIFIC REPORTS (2016)
The Essential Role of H19 Contributing to Cisplatin Resistance by Regulating Glutathione Metabolism in High-Grade Serous Ovarian Cancer
Zhi-Guo Zheng et al.
SCIENTIFIC REPORTS (2016)
β-elemene sensitizes hepatocellular carcinoma cells to oxaliplatin by preventing oxaliplatin-induced degradation of copper transporter 1
Xiaoqiang Li et al.
SCIENTIFIC REPORTS (2016)
miRNA-378 reverses chemoresistance to cisplatin in lung adenocarcinoma cells by targeting secreted clusterin
Xuesong Chen et al.
SCIENTIFIC REPORTS (2016)
The Functions of Metallothionein and ZIP and ZnT Transporters: An Overview and Perspective
Tomoki Kimura et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Overexpression of long non-coding RNA PVT1 in gastric cancer cells promotes the development of multidrug resistance
Xian-wen Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Catechols and 3-hydroxypyridones as inhibitors of the DNA repair complex ERCC1-XPF
Timothy M. Chapman et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
HMGB1-mediated autophagy modulates sensitivity of colorectal cancer cells to oxaliplatin via MEK/ERK signaling pathway
Weijun Liu et al.
CANCER BIOLOGY & THERAPY (2015)
Serum metallothionein in patients with testicular cancer
Blanka Tariba et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2015)
Autophagy contributes to the enrichment and survival of colorectal cancer stem cells under oxaliplatin treatment
Hao-Zheng Yang et al.
CANCER LETTERS (2015)
Xc- inhibitor sulfasalazine sensitizes colorectal cancer to cisplatin by a GSH-dependent mechanism
Ming-zhe Ma et al.
CANCER LETTERS (2015)
miR-634 Activates the Mitochondrial Apoptosis Pathway and Enhances Chemotherapy-Induced Cytotoxicity
Naoto Fujiwara et al.
CANCER RESEARCH (2015)
Heparanase Enhances Tumor Growth and Chemoresistance by Promoting Autophagy
Anna Shteingauz et al.
CANCER RESEARCH (2015)
MiR-205 and miR-218 expression is associated with carboplatin chemoresistance and regulation of apoptosis via Mcl-1 and Survivin in lung cancer cells
Paul Zarogoulidis et al.
CELLULAR SIGNALLING (2015)
Role of mismatch repair proteins in the processing of cisplatin interstrand cross-links
Akshada Sawant et al.
DNA REPAIR (2015)
The overexpression and nuclear translocation of Trx-1 during hypoxia confers on HepG2 cells resistance to DDP, and GL-V9 reverses the resistance by suppressing the Trx-1/Ref-1 axis
Li Zhao et al.
FREE RADICAL BIOLOGY AND MEDICINE (2015)
Targeting autophagy to overcome drug resistance in cancer therapy
Ankit Kumar et al.
FUTURE MEDICINAL CHEMISTRY (2015)
A common polymorphism in the 5′ UTR of ERCC5 creates an upstream ORF that confers resistance to platinum-based chemotherapy
Joanna Somers et al.
GENES & DEVELOPMENT (2015)
Resistance to therapy in BRCA2 mutant cells due to loss of the nucleosome remodeling factor CHD4
Shawna Guillemette et al.
GENES & DEVELOPMENT (2015)
The anti-malarial chloroquine suppresses proliferation and overcomes cisplatin resistance of endometrial cancer cells via autophagy inhibition
Tomohiko Fukuda et al.
GYNECOLOGIC ONCOLOGY (2015)
Autophagic flux promotes cisplatin resistance in human ovarian carcinoma cells through ATP-mediated lysosomal function
Liwei Ma et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
miR-873 acts as a novel sensitizer of glioma cells to cisplatin by targeting Bcl-2
Xiong Chen et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Inhibition of cisplatin-resistance by RNA interference targeting metallothionein using reducible oligo-peptoplex
Jong-Hwan Lee et al.
JOURNAL OF CONTROLLED RELEASE (2015)
miR-148b reverses cisplatin-resistance in non-small cell cancer cells via negatively regulating DNA (cytosine-5)-methyltransferase 1(DNMT1) expression
Chengguang Sui et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
miR-634 restores drug sensitivity in resistant ovarian cancer cells by targeting the Ras-MAPK pathway
Marijn T. M. van Jaarsveld et al.
MOLECULAR CANCER (2015)
MEK Inhibition Overcomes Cisplatin Resistance Conferred by SOS/MAPK Pathway Activation in Squamous Cell Carcinoma
Li Ren Kong et al.
MOLECULAR CANCER THERAPEUTICS (2015)
CITED2 silencing sensitizes cancer cells to cisplatin by inhibiting p53 trans-activation and chromatin relaxation on the ERCC1 DNA repair gene
Yu-Chin Liu et al.
NUCLEIC ACIDS RESEARCH (2015)
Dihydromyricetin Enhances the Chemo-Sensitivity of Nedaplatin via Regulation of the p53/BcI-2 Pathway in Hepatocellular Carcinoma Cells
Lianggui Jiang et al.
PLOS ONE (2015)
Glutathione depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in vivo (vol 5, e1505, 2014)
C. R. R. Rocha et al.
CELL DEATH & DISEASE (2015)
Epithelial-mesenchymal status renders differential responses to cisplatin in ovarian cancer
Q. H. Miow et al.
ONCOGENE (2015)
EGCG Enhances Cisplatin Sensitivity by Regulating Expression of the Copper and Cisplatin Influx Transporter CTR1 in Ovary Cancer
Xuemin Wang et al.
PLOS ONE (2015)
Multidrug Resistance-Associated Protein 2 (MRP2) Mediated Transport of Oxaliplatin-Derived Platinum in Membrane Vesicles
Khine Myint et al.
PLOS ONE (2015)
Mechanism of Cisplatin-Induced Cytotoxicity Is Correlated to Impaired Metabolism Due to Mitochondrial ROS Generation
Yong-Min Choi et al.
PLOS ONE (2015)
Targeting Apoptosis Pathways for New Cancer Therapeutics
Longchuan Bai et al.
ANNUAL REVIEW OF MEDICINE, VOL 65 (2014)
Chromatin status of apoptosis genes correlates with sensitivity to chemo-, immune- and radiation therapy in colorectal cancer cell lines
Anne Benard et al.
APOPTOSIS (2014)
Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers
T. Golan et al.
BRITISH JOURNAL OF CANCER (2014)
Induction of autophagy counteracts the anticancer effect of cisplatin in human esophageal cancer cells with acquired drug resistance
Le Yu et al.
CANCER LETTERS (2014)
Pharmacogenetics of the DNA repair pathways in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy
Ivana Sullivan et al.
CANCER LETTERS (2014)
miR-let-7f-1 regulates SPARC mediated cisplatin resistance in medulloblastoma cells
Padmavathi Pannuru et al.
CELLULAR SIGNALLING (2014)
Reduced Expression of miRNA-27a Modulates Cisplatin Resistance in Bladder Cancer by Targeting the Cystine/Glutamate Exchanger SLC7A11
Ross M. Drayton et al.
CLINICAL CANCER RESEARCH (2014)
miR-495 Enhances the Sensitivity of Non-Small Cell Lung Cancer Cells to Platinum by Modulation of CopperTransporting P-type Adenosine Triphosphatase A (ATP7A)
Liqiang Song et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2014)
Copper transporter CTR1 expression and tissue platinum concentration in non-small cell lung cancer
Eric S. Kim et al.
LUNG CANCER (2014)
Copper transporter 2 regulates intracellular copper and sensitivity to cisplatin
Carlos P. Huang et al.
METALLOMICS (2014)
JWA reverses cisplatin resistance via the CK2-XRCC1 pathway in human gastric cancer cells
W. Xu et al.
CELL DEATH & DISEASE (2014)
DNA damage-induced cell death: From specific DNA lesions to the DNA damage response and apoptosis
Wynand P. Roos et al.
CANCER LETTERS (2013)
Enhanceosomes as integrators of hypoxia inducible factor (HIF) and other transcription factors in the hypoxic transcriptional response
Matthew R. Pawlus et al.
CELLULAR SIGNALLING (2013)
Prostate Cancer, miRNAs, Metallothioneins and Resistance to Cytostatic Drugs
V. Pekarik et al.
CURRENT MEDICINAL CHEMISTRY (2013)
Autophagic control of cell stemness'
Huize Pan et al.
EMBO MOLECULAR MEDICINE (2013)
Impaired Glutathione Synthesis in Neurodegeneration
Koji Aoyama et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Chk1/2 Inhibition Overcomes the Cisplatin Resistance of Head and Neck Cancer Cells Secondary to the Loss of Functional p53
Mayur A. Gadhikar et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Hypoxia inducible factor-1α induces chemoresistance phenotype in non-Hodgkin lymphoma cell line via up-regulation of Bcl-xL
Marco A. Hernandez-Luna et al.
LEUKEMIA & LYMPHOMA (2013)
Suppression of Jab1/CSN5 induces radio- and chemo-sensitivity in nasopharyngeal carcinoma through changes to the DNA damage and repair pathways
Y. Pan et al.
ONCOGENE (2013)
Endoplasmic Reticulum Stress Is Involved in the Response of Human Laryngeal Carcinoma Cells to Carboplatin but Is Absent in Carboplatin-Resistant Cells
Anamaria Brozovic et al.
PLOS ONE (2013)
Low ERCC1 expression is associated with prolonged survival in patients with bladder cancer receiving platinum-based neoadjuvant chemotherapy
Muhammet Fuat Ozcan et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2013)
Zinc chelation: a metallothionein 2A's mechanism of action involved in osteosarcoma cell death and chemotherapy resistance
N. Habel et al.
CELL DEATH & DISEASE (2013)
Carboplatin and oxaliplatin in sequenced combination with bortezomib in ovarian tumour models
Zaynab Al-Eisawi et al.
JOURNAL OF OVARIAN RESEARCH (2013)
Resistance and gain-of-resistance phenotypes in cancers harboring wild-type p53
Michelle Martinez-Rivera et al.
BIOCHEMICAL PHARMACOLOGY (2012)
BRCA1/2 mutations and expression: Response to platinum chemotherapy in patients with advanced stage epithelial ovarian cancer
Rebecca Byler Dann et al.
GYNECOLOGIC ONCOLOGY (2012)
Replacement of cisplatin with nedaplatin in a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma
Akiko Kuwahara et al.
International Journal of Medical Sciences (2012)
The CXXC motifs in the metal binding domains are required for ATP7B to mediate resistance to cisplatin
Roohangiz Safaei et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2012)
Overcoming Platinum Resistance through the Use of a Copper-Lowering Agent
Siqing Fu et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Role of multidrug resistance protein 2 (MRP2) in chemoresistance and clinical outcome in oesophageal squamous cell carcinoma
M. Yamasaki et al.
BRITISH JOURNAL OF CANCER (2011)
Role of Endonucleases XPF and XPG in Nucleotide Excision Repair of Platinated DNA and Cisplatin/Oxaliplatin Cytotoxicity
Nora Graf et al.
CHEMBIOCHEM (2011)
Secondary Somatic Mutations Restoring BRCA1/2 Predict Chemotherapy Resistance in Hereditary Ovarian Carcinomas
Barbara Norquist et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Copper Transporter 2 Regulates Endocytosis and Controls Tumor Growth and Sensitivity to Cisplatin In Vivo
Brian G. Blair et al.
MOLECULAR PHARMACOLOGY (2011)
The Mutational Landscape of Head and Neck Squamous Cell Carcinoma
Nicolas Stransky et al.
SCIENCE (2011)
Targeting the prodeath and prosurvival functions of autophagy as novel therapeutic strategies in cancer
Kevin N. Dalby et al.
AUTOPHAGY (2010)
Increased levels and defective glycosylation of MRPs in ovarian carcinoma cells resistant to oxaliplatin
Giovanni Luca Beretta et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Differential transport of platinum compounds by the human organic cation transporter hOCT2 (hSLC22A2)
H. Burger et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Enhancing Tumor-Specific Uptake of the Anticancer Drug Cisplatin with a Copper Chelator
Seiko Ishida et al.
CANCER CELL (2010)
Silencing MRP4 by small interfering RNA reverses acquired DDP resistance of gastric cancer cell
Yan-Hong Zhang et al.
CANCER LETTERS (2010)
The relationship between cisplatin-induced reactive oxygen species, glutathione, and BCL-2 and resistance to cisplatin
Anamaria Brozovic et al.
CRITICAL REVIEWS IN TOXICOLOGY (2010)
The status of platinum anticancer drugs in the clinic and in clinical trials
Nial J. Wheate et al.
DALTON TRANSACTIONS (2010)
Downregulation of XPF-ERCC1 enhances cisplatin efficacy in cancer cells
Sanjeevani Arora et al.
DNA REPAIR (2010)
An Adsorptive Transfer Technique Coupled with Brdicka Reaction to Reveal the Importance of Metallothionein in Chemotherapy with Platinum Based Cytostatics
Sona Krizkova et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2010)
Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary
Ashour Ahmed Ahmed et al.
JOURNAL OF PATHOLOGY (2010)
Copper Transporters and the Cellular Pharmacology of the Platinum-Containing Cancer Drugs
Stephen B. Howell et al.
MOLECULAR PHARMACOLOGY (2010)
Hypoxia-Inducible Factor 1α Determines Gastric Cancer Chemosensitivity via Modulation of p53 and NF-κB
Nadine Rohwer et al.
PLOS ONE (2010)
Cisplatin Interaction with Amino Acids Cysteine and Methionine from Gas Phase to Solutions with Constant pH
Tomas Zimmermann et al.
INTERDISCIPLINARY SCIENCES-COMPUTATIONAL LIFE SCIENCES (2010)
Hypoxia-inducible factor-1 alpha, in association with inflammation, angiogenesis and MYC, is a critical prognostic factor in patients with HCC after surgery
Chen-Xin Dai et al.
BMC CANCER (2009)
Modes of p53 Regulation
Jan-Philipp Kruse et al.
CELL (2009)
Copper Transporter 2 Regulates the Cellular Accumulation and Cytotoxicity of Cisplatin and Carboplatin
Brian G. Blair et al.
CLINICAL CANCER RESEARCH (2009)
Human copper transporters: mechanism, role in human diseases and therapeutic potential
Arnab Gupta et al.
FUTURE MEDICINAL CHEMISTRY (2009)
Increased levels of copper efflux transporter ATP7B are associated with poor outcome in colorectal cancer patients receiving oxaliplatin-based chemotherapy
Eva Martinez-Balibrea et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Crystal Structures of Cisplatin Bound to a Human Copper Chaperone
Amie K. Boal et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
The ERCC1/XPF endonuclease is required for completion of homologous recombination at DNA replication forks stalled by inter-strand cross-links
Ali Z. Al-Minawi et al.
NUCLEIC ACIDS RESEARCH (2009)
Prognostic significance of hypoxia-inducible factor-1α, TWIST1 and Snail expression in resectable non-small cell lung cancer
J-J Hung et al.
THORAX (2009)
The role of cellular accumulation in determining sensitivity to platinum-based chemotherapy
Matthew D. Hall et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2008)
Altered localisation of the copper efflux transporters ATP7A and ATP7B associated with cisplatin resistance in human ovarian carcinoma cells
Ganna V. Kalayda et al.
BMC CANCER (2008)
Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype
Binod Kumar et al.
CANCER RESEARCH (2008)
Transcriptional control of human p53-regulated genes
Todd Riley et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Transport of cisplatin by the copper efflux transporter ATP7B
Roohangiz Safaei et al.
MOLECULAR PHARMACOLOGY (2008)
HYPOXIA AND METABOLISM SERIES - TIMELINE The impact of O2 availability on human cancer
Jessica A. Bertout et al.
NATURE REVIEWS CANCER (2008)
Enhanced repair of DNA interstrand crosslinking in ovarian cancer cells from patients following treatment with platinum-based chemotherapy
P. Wynne et al.
BRITISH JOURNAL OF CANCER (2007)
Human copper transporter 2 is localized in late endosomes and lysosomes and facilitates cellular copper uptake
Peter V. E. Van den Berghe et al.
BIOCHEMICAL JOURNAL (2007)
Expression of hypoxia-inducible factor 1α, hypoxia-inducible factor 2α, and von Hippel-Lindau protein in epitheLiaL ovarian neoplasms and allelic loss of von Hippel-Lindau gene:: nuclear expression of hypoxia-inducible factor 1α is an independent prognostic factor in ovarian carcinoma
Ryosuke Osada et al.
HUMAN PATHOLOGY (2007)
Differential contribution of organic cation transporters, OCT2 and MATE1, in platinum agent-induced nephrotoxicity
Sachiko Yokoo et al.
BIOCHEMICAL PHARMACOLOGY (2007)
The role of ubiquitination in the direct mitochondrial death program of p53
Natasha D. Marchenko et al.
CELL CYCLE (2007)
Tumor microenvironment: The role of the tumor stroma in cancer
Hanchen Li et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
Direct cellular responses to platinum-induced DNA damage
Yongwon Jung et al.
CHEMICAL REVIEWS (2007)
Mitochondria and reactive oxygen species in renal cancer
Eric Hervouet et al.
BIOCHIMIE (2007)
ABCC2 (MRP2, cMOAT) can be localized in the nuclear membrane of ovarian carcinomas and correlates with resistance to cisplatin and clinical outcome
Pawel Surowiak et al.
CLINICAL CANCER RESEARCH (2006)
The internalization and degradation of human copper transporter 1 following cisplatin exposure
Alison K. Holzer et al.
CANCER RESEARCH (2006)
Cisplatin and oxaliplatin, but not carboplatin and nedaplatin, are substrates for human organic cation transporters (SLC22A1-3 and multidrug and toxin extrusion family)
Atsushi Yonezawa et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Contribution of the major copper influx transporter CTR1 to the cellular accumulation of cisplatin, carboplatin, and oxaliplatin
Alison K. Holzer et al.
MOLECULAR PHARMACOLOGY (2006)
Molecular mechanisms of mammalian global genome nucleotide excision repair
LCJ Gillet et al.
CHEMICAL REVIEWS (2006)
Platinum anticancer drug damage enforces a particular rotational setting of DNA in nucleosomes
AJ Danford et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Augmentation of cisplatin sensitivity in cisplatin-resistant human bladder cancer cells by modulating glutathione concentrations and glutathione-related enzyme activities
SS Byun et al.
BJU INTERNATIONAL (2005)
Recognition and processing of cisplatin- and oxaliplatin-DNA adducts
SG Chaney et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2005)
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2
LT Vassilev et al.
SCIENCE (2004)
Modulation of the cellular pharmacology of cisplatin and its analogs by the copper exporters ATP7A and ATP7B
G Samimi et al.
MOLECULAR PHARMACOLOGY (2004)
Small molecule RITA binds to p53, blocks p53-HDM-2 interaction and activates p53 function in tumors
N Issaeva et al.
NATURE MEDICINE (2004)
DNA strand breaks and apoptosis induced by oxaliplatin in cancer cells
S Faivre et al.
BIOCHEMICAL PHARMACOLOGY (2003)
Current status of the molecular mechanisms of anticancer drug-induced apoptosis - The contribution of molecular-level analysis to cancer chemotherapy
R Kim et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2002)
Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals
S Ishida et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Recognition of cisplatin adducts by cellular proteins
M Kartalou et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2001)
Oxaliplatin-induced damage of cellular DNA
JM Woynarowski et al.
MOLECULAR PHARMACOLOGY (2000)
A family of drug transporters: The multidrug resistance-associated proteins
P Borst et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
分享论文
